Language selection

Search

Patent 2040959 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2040959
(54) English Title: GELLAN GUM FIBERS
(54) French Title: FIBRES DE GOMME GELLAN
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61L 15/28 (2006.01)
  • D1F 9/00 (2006.01)
(72) Inventors :
  • COLEGROVE, GEORGE T. (United States of America)
(73) Owners :
  • MONSANTO COMPANY
(71) Applicants :
  • MONSANTO COMPANY (United States of America)
(74) Agent: LAVERY, DE BILLY, LLP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1991-04-22
(41) Open to Public Inspection: 1991-10-24
Examination requested: 1998-02-04
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
513,412 (United States of America) 1990-04-23

Abstracts

English Abstract


9183P/5582A
K-2099
TITLE OF THE INVENTION
GELLAN GUM FIBERS
ABSTRACT OF THE DISCLOSURE
Gellan gum fibers are produced by extrusion
into a gelling salt bath. Optionally, other gums may
be co-extruded with the gellan gum. The fibers are
useful for the production of wound dressings and
catamenial devices.


Claims

Note: Claims are shown in the official language in which they were submitted.


9183P/5582A -8- K-2099
WHAT IS CLAIMED IS:
1. A fiber comprises gellan gum and one or
more of a second gum, which is algin, xanthan, or
locust bean gum, wherein the ratio gellan gum to said
second gum is at least 2:1.
2. A method of producing gellan gum fibers
which comprises extruding a 2-6% gellan gum solution
into a coagulating bath comprising 0.5-5.0% gelling
salts.
3. The method of Claim 2 wherein the
gelling salts are of calcium or magnesium.
4. The method of Claim 2 wherein the gum
solution comprises one or more of a second gum, which
is algin, xanthan, or locust bean gum, and wherein
the ratio of gellan to said second gum is at least
2:1.

Description

Note: Descriptions are shown in the official language in which they were submitted.


- - 2 ~
9183P/5582A
-1- K-2099
TITLE OF THE INVENTION
GELLAN GUM FIBERS
BACKGROUND OF THIS INVENTION
Alginate fibers have been known for use in
surgical dressings for some time. UK 653,341 is an
example of an early disclosure of the use of calcium
alginate materials in surgical dressings. The
earliest such materials were calcium alginate fibers,
but they suffered from the disadvantage of belng
quite insoluble in water or wound exudate matter.
Later a portion of the calcium ions in calcium
alginate was exchanged with other cations, whose
alginate salts are soluble. UK 653,341 therefore
proposed that some of the calcium ions be replaced
with sodium ions, to form a mixed salt algina~e.

--` 2 ~ 9
9183P/5582A -2- K-2099
Other uses for alginate fibers have been
proposed which involve shaping the fiber~ as by
weaving or knitting into sheets or pads. -These
materials are useful because they absorb water and
swell but retain their shape and structural integrity.
Other polysaccharides have been proposed for
fiber formation. For example, Burrow et al. (EP
232,121) have described cross-linked polysaccharides
~starch, gellan, curdlan, pullulan, and glycogen)
fibers. These cross-linked fibers are produced by
extruding a dissolved carboxylate ester of the
polysaccharide while simultaneously hydrolyzing the
ester groups and cross-linking the resultant hydro2yl
groups.
SUMMARY OF THIS INVENTION
It has now been found that gellan gum fibers
may be produced by extrusion~of a gum soIution into a
gelling bath. The process, advantageously, does not
require esterification and subsequent hydrolysis.
The process also produces hybrid fibers comprising
gellan and one or more additional gums.
DETAILED DESCRIPTION
By the t~rm "gellan gum", as used herein, is
meant the extracellularly produced gum made by the
heteropolysaccharide-producing bacterium Pseudomonas
elode~, ATCC 31461, by the whole culture fermentation
under a variety of conditions of a medium
comprising: a fermentable carbohydrate, a nitrogen
source, and other appropriate nutrients. Included is
the nativet deacylated, partially deacylated, and
clarified form~ therefore. Gellan gum is also known
as S-60.

o ~
-
9183P/5582A -3- K-2099
Processes for producing gellan gum are
well-known in the art, e.g., U.S. Patents 4,326,052,
4,326,053, 4,377,636, 4,385,126, and 4,503,084.
Particularly preferred is deacylated gellan
gum, described in U.S.P. 4,326,05Z.
In general, gellan ~um solutions containing
2-6% gum (percentages herein are on a wt./wt. basis
unless stated otherwise) are extruded through fine
orifices into coagulating baths containing various
lo cations to produce filamentous fibers which can be
used in wound dressings, catamenial devlces, etc.
Gellan gum may be used by itself or in combination
with other polysaccharides æuch as alginates, xanthan
gum, and locust bean gum. Solutions may be extruded
cold (room temperature-50C) ox hot (50-80C); if
hot, the addition of another gum is usually
necessary. Gellan gum is especially useful for
producing fibers containing magnesium for controlled
release of that cation. The fibers may also contain
known wound hea~ing agents.
When the gellan gum is co-extruded with
other polysaccharides, this produces fibers with
hybrid properties.
The bath of gelling salts is an aqueous
solution of 0.5-5% of a soluble salt, the cation of
which may be mono-, di-, or tri-valent and selected
from those of Groups I, II, and III of the Perodic
Table, especially Na+, K+9 Ca~+, Mg~, and
Al+++. Ca~+ and Mg+~ are especially
preferred. The anion may be chloride sulfate,
lactate, phosphate, carbonate, gluconate, or
tartrate. Residence time is the bath is 5 seconds -
5 minutes.

-: -` 204~5~
,.
9183P/5582A -4- K-2099
When a second polysaccharide is used it is
one which exhibits a high viscosity when hot; 1n
particular, algin, xanthan gum, and locust bean gum
or combinations of these. The second gum can replace
up to 33 1/3% of the gellan gum; i.e., up to 2a/~ of a
6% gum solution may be comprised of one or more of a
second polysaccharide.
In the final product, therefore, the ratio
of gellan gum to said second gum is at least 2:1.
lo By algin is meant the soluble derivatives of
alginic acid, which may be chemically extracted from
all species of Phaeophvceae, brown algae. The term
is intended to include the soluble salts of alginic
acid (e.g., sodium, potassium, or ammonium alginate)
and the salts of its ethers (e.g., propylene glycol
alginate).
By xanthan gum is meant the biosynthetic
polysaccharide produced by the organism Xanthomonas
campestris by the whole culture fermentation of a
medium comprising a fermentable carbohydrate, a
nitrogen source and appropriate other nutrients.
Xanthan gum preparation is described in
numerous publications and patents, e.g., ~.S. Pat.
Nos. 3,671,398; 3,594,280; 3,591,578; 3,481,889;
2s 3,433,708; 3,427,226; 3,391,061; 3,391,060;
3,271,267; 3,251,749; and 3j020,206.
Locust bean gum (lbg) is an extract of the
locust bean or carob, Cera~onia sili~ua. It is
commercially available and used as a stabilizer in
foods such as ice cream, sausages, and cheese.
Gellan gum is normally gelled by heating an
aqueous solution to dissolve the gum then simply

. . ~
9183P/5582A -5- K-2099
cooling to produce a gel, provided cations are
present. It is also known that solutions may be
prepared cold in distilled or deionized water by the
addition of a small amount of sequestrant. The
sequestrants which can be used in this invention
include trisodium orthophosphate (TSP), ethylenedi-
aminetetraacetic acid (EDTA), sodium citrate, tetraso-
dium pyrophosphate (TSPP), sodium hexametaphospha~e
(Calgon) and the like. Gellan gum fibers can
therefore be prepared by forcing a solution of ~.0%
deacylated, clarified gellan gum containing 0.25%
sodium citrate in deionized water through a nozzle
having a diameter of eleven thousandth of an inch
into a 2% calcium chloride bath where fiber formation
immediately occurs.
Gellan gum is particularly useful for
forming fibers containing magnesium ions as it also
gels in the presence of magnesium salts. The 2%
gellan gum solution above was also forced into a bath
containing 2% magnesium sulfate wherein fiber
formation also immediately occurred. Fibers
containing a source of magnesium are valuable
additives to catamenial devices such as tampons where
magnesium ions are said to prevent toxic shock
syndrome. Magnesium alginate is soluble in water;
therefore it cannot be formed by useful methods but
must be formed by ion exchange ~rom insoluble calcium
alginate fibers already produced by the usual
methods. A small amount can be formed simultaneously
with gellan gum fibers however, by incorporating
sodium alginate into gellan gum solutions before
extrusion into the gelling bath. Up to about 25%

2~4~
,;
9183P/5582A -6- K-2099
sodium alginate based on the weight of the gellan gum
is possible without destroying the fiber integrity.
Thus, 2.0% gellan gum plus 0.5% alginate having a
viscosity of 95,000 cP as measured on a Brook~ield
LVT viscometer, spindle 4, 6 rpm, 25~C was extruded
into a bath containing 2~/o magnesium sulfate wherein
gelation and fiber formation immediately occurred.
Since the alginate tends to swell slightly the bath
may also contain up to 50% of a lower alcohol such as
isopropanol to minimize swelling. The same solution
above was extruded into a 2% calcium chloride bath
wherein fiber formation immediately occurred.
Fiber formation from hot solutions i9 more
complicated. Gellan gum solutions have high
viscosity when cold but low viscosity w~en heated,
which makes it possible to prepare more concentrated
solutions which gel more rapidly with higher gel
strength. Fiber production by extrusion from~hot gum
solutions into a bath were not successful, however,
because the low viscosity solution dispersed into~
flocs without forming a continuous fiber. It has
been found that the addition of another
polysaccharide which produces more viscosity at
temperatures of 50-80C make fiber formation
possible. Thus, a hot 4% gellan gum solution ~orced
through a nozzle into a 2% calcium chloride bath
instantly dispersed while a 4% gellan gum solution
containing 1% sodium alginate having a viscosity of
4,400 cP as measured on a Brookfield LVT viscometer,
spindle 4, 60 rpm, 70~C formed fibers under the same
conditions. The high viscosity thickeners xanthan
gum and locust bean gum or a combination of the two
also produced ~ibers when combined with the gellan
gum at levels of 0.5-1.0%.

- -- 2 ~
9183P/5582A -7- K-2099
The fibers of this invention can be used in
various forms. If a non-woven fabric is to be
prepared, and this is the fabric of choice, a cotton
card may be used to form a web, which may then be
cross-lapped and then needle punched in conventional
equipment.
If a woven fabric is to be prepared, the
fibers may be carded and then spun into a yarn, which
can be woven in a conventional loom. Alternatively,
lo the fibers may be collected in a spinning box,
according to the method of Tallis (UK S68,177) and
woven. If a knitted fabric is to be prepared, the
fibers can be prepared as a continuous filament yarn
(again according to UK 568,177) which is then knitted
on a conventional knitting machine.
The fiber end product (e.g., a pad) may
include one or more antimicrobial (for example,
antibacterial or antifungal) agents and/or one or
more local anesthetics (for example, procaine) and
additionally or alternatively one or more
pharmaceutical agents.
.. . .

Representative Drawing

Sorry, the representative drawing for patent document number 2040959 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC deactivated 2011-07-26
Inactive: First IPC derived 2006-03-11
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 2000-04-25
Application Not Reinstated by Deadline 2000-04-25
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1999-04-22
Letter Sent 1998-03-03
Inactive: Status info is complete as of Log entry date 1998-03-03
Inactive: Application prosecuted on TS as of Log entry date 1998-03-03
Request for Examination Requirements Determined Compliant 1998-02-04
All Requirements for Examination Determined Compliant 1998-02-04
Application Published (Open to Public Inspection) 1991-10-24

Abandonment History

Abandonment Date Reason Reinstatement Date
1999-04-22

Maintenance Fee

The last payment was received on 1998-04-02

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Request for examination - standard 1998-02-04
MF (application, 7th anniv.) - standard 07 1998-04-22 1998-04-02
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MONSANTO COMPANY
Past Owners on Record
GEORGE T. COLEGROVE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1993-11-26 1 14
Abstract 1993-11-26 1 15
Claims 1993-11-26 1 19
Description 1993-11-26 7 247
Reminder - Request for Examination 1997-12-22 1 117
Acknowledgement of Request for Examination 1998-03-02 1 179
Courtesy - Abandonment Letter (Maintenance Fee) 1999-05-19 1 186
Fees 1998-04-01 1 43